
Cure Quick Pharma Private Limited
About Cure Quick Pharma Private Limited
Data last updated:
Cure Quick Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC287272. Its GSTIN is 02AAGCC2494M1ZJ (Himachal Pradesh).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹38 Lakh. It is led by directors Siddharth and Harish Kumar Digani.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at House No. 38 Sfs Flats Block – Bu Pitampura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2021, the company reported a revenue of ₹1.52 Cr, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹52,984 (net margin -0.3%) and EBITDA of ₹3.27 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹8.8 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cure Quick Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 38 Sfs Flats Block – Bu Pitampura, New Delhi, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cure Quick Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cure Quick Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cure Quick Pharma Private Limited, buy the company report.
Financials of Cure Quick Pharma Private Limited
FY 2021 filings availableCure Quick Pharma Private Limited reported revenue of ₹1.52 Cr (down 65% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 65% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA fell 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.52 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹52,984 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cure Quick Pharma Private Limited, buy the company report.
Board of directors of Cure Quick Pharma Private Limited
Cure Quick Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Also directs: Cure Quick Remedies Private Limited | Director | 18 Jan 2024 | 2 Years 10 Months | Current |
| Harish Kumar Digani Also directs: Cure Quick Remedies Private Limited | Director | 09 Nov 2015 | 11 Years 0 Months | Current |
Peer comparison
Cure Quick Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shree Vishwamitra Ayurved Pharmaceuticals Private Limited | ₹1.53 Cr (FY 2025) | 10.0% | Ahmedabad, Gujarat, India | |||
| Afd Laboratories Private Limited | ₹1.53 Cr (FY 2023) | 3.0% | Mumbai, Maharashtra, India | |||
| Cure Quick Pharma Private Limitedthis company | ₹1.52 Cr (FY 2021) | -₹52,984 | -0.3% | -65.0% | New Delhi, Delhi, India | |
| Sahana Pharmaceuticals Private Limited | ₹1.52 Cr (FY 2025) | 41.0% | Nagercoil, Tamil Nadu, India | |||
| Bharat Remedies Pvt Ltd | ₹1.52 Cr (FY 2024) | -23.0% | Punjab, India |
To see the full peer comparison of Cure Quick Pharma Private Limited, buy the company report.
Auditor
Cure Quick Pharma Private Limited is audited by GROVER DINESH & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GROVER DINESH & ASSOCIATES | FY 2021 | 012455N |
Shareholding
The shareholding of Cure Quick Pharma Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cure Quick Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jun 2020 | 100349053 | State Bank of India | ₹8.8 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Cure Quick Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Civil suit | Filed against the company by M/S Shilex Chemicals Private Limited | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by M/S Medisys Biotech Pvt Ltd | Disposed |
To see the full case history of Cure Quick Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cure Quick Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cure Quick Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAGCC2494M1ZJ | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cure Quick Pharma Private Limited, buy the company report.
Recent activity
Cure Quick Pharma Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Rajesh Kumar ceased to be Director on 19 Jan 2024.
Frequently asked questions
Cure Quick Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 November 2015 (11+ years old) and is registered under CIN U24100DL2015PTC287272.
Cure Quick Pharma has 2 current directors:
- Siddharth - Director
- Harish Kumar Digani - Director
The latest financial statements of Cure Quick Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Cure Quick Pharma is 02AAGCC2494M1ZJ, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Cure Quick Pharma is U24100DL2015PTC287272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cure Quick Pharma has 2 court cases on record: 2 filed against it.
Cure Quick Pharma was incorporated on 09 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cure Quick Pharma by revenue are Shree Vishwamitra Ayurved Pharmaceuticals Private Limited, Afd Laboratories Private Limited, Sahana Pharmaceuticals Private Limited, Bharat Remedies Pvt Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajesh Kumar ceased to be Director on 19 Jan 2024. Siddharth was appointed as Director on 18 Jan 2024. Harish Kumar Digani was appointed as Director on 09 Nov 2015.
The registered office of Cure Quick Pharma is at House No. 38 Sfs Flats Block – Bu Pitampura, New Delhi, Delhi, India – 110034.
Cure Quick Pharma operates in the pharma industry, in the drug formulation and development segment.

